The Valley Desk

ArticleAmerican heart journalPublished

Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Lankenau Institute for Medical Research, Thomas Jefferson University, with Main Line Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
American heart journal
Published
Subject terms
Humans; Atrial Fibrillation; Atrial Flutter; Hemorrhage; Pyrazoles; Pyridones; Factor XIa; Anticoagulants; Double-Blind Method; Aged; Middle Aged; Female
PubMed ID
39214801
Added to directory
Source checked

Report a correction or request removal